|
|
Investigating whole-body innate immune activation in Alzheimer's disease using PET imaging and immune profiling |
| 1 K99 AG070105-01 |
|
NIA |
2021 |
|
|
In Vivo Model and Histology Core |
| 1 P01 AG066603-01A1 |
|
NIA |
2021 |
|
|
Biomarker |
| 1 P30 AG072947-01 |
|
NIA |
2021 |
|
|
Research Education Component |
| 1 P30 AG072959-01 |
|
NIA |
2021 |
|
|
Skin biomarkers for diagnosing and characterizing AD and ADRD |
| 1 R01 AG067607-01A1 |
|
NIA |
2021 |
|
|
Hypothalamic and metabolic dysfunction in Alzheimers disease |
| 1 R01 AG070868-01 |
|
NIA |
2021 |
|
|
Gut barrier function in Alzheimer’s disease |
| 1 R01 AG070973-01 |
|
NIA |
2021 |
|
|
Exosome biology in Alzheimers disease and concussion. |
| 1 R01 AG071228-01A1 |
|
NIA |
2021 |
|
|
Decoding the impact of sex differences on Alzheimers disease risk |
| 1 R01 AG074009-01 |
|
NIA |
2021 |
|
|
Systems Genetics Analysis of Sex Differences in Alzheimers Disease |
| 1 R01 AG074012-01 |
|
NIA |
2021 |
